CIK 0001828673
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825024477
- Phone
- +1 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-11 | Rhode Peter See Remarks | Option exercise | +14,000 | $0.14 | $2K | 77,500 |
| 2023-12-11 | Rhode Peter See Remarks | Option exercise · Stock Option (Right to Buy) | −14,000 | 22,427 | ||
| 2023-11-17 | Rhode Peter See Remarks | Option exercise | +15,000 | $0.14 | $2K | 63,500 |
| 2023-11-17 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −15,000 | 36,427 | ||
| 2022-01-14 | Rhode Peter See Remarks | Option exercise | +1,714 | $0.21 | $360 | 48,499 |
| 2022-01-14 | Rhode Peter See Remarks | Option exercise | +1 | $0.14 | $0 | 48,500 |
| 2022-01-14 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −1,714 | 6,857 | ||
| 2022-01-14 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −1 | 51,427 | ||
| 2021-09-08 | Rhode Peter See Remarks | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-07-22 | Rhode Peter See Remarks | Purchase | +12,500 | $8.00 | $100K | 46,785 |
Page 1 of 1 · 10 trades